ask="266.00"
ask_size="300"
average_daily_volume="391268"
bid="16.26"
bid_size="200"
book_value="3.21"
change="-0.08"
change_from_200_day_moving_average="7.76"
change_from_50_day_moving_average="2.52"
change_from_52_week_high="-1.73"
change_From_52_week_low="16.33"
change_in_percent="-0.36%"
close="22.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.47"
ex_dividend_date="N/A"
float_shares="7150000"
high="23.50"
high_52_weeks="23.75"
last_trade_date="2/24/2017"
last_trade_price="22.02"
last_trade_size="6125"
last_trade_time="4:00pm"
low="21.86"
low_52_weeks="5.69"
market_capitalization="219.17M"
moving_average_200_day="14.26"
moving_average_50_day="19.50"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="22.48"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+54.38%"
percent_change_from_50_day_moving_average="+12.90%"
percent_change_from_52_week_high="-7.28%"
percent_change_from_52_week_low="+286.99%"
previous_close="22.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.89"
price_per_sales="3891.47"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.02"
stock_exchange="NGM"
symbol="ZYNE"
volume="871217"
weeks_range_52="5.69 - 23.75"
